Relationship between chromosome 8 alterations and Gleason score in prostatic adenocarcinoma

Chinese Journal of Pathology

Volumn 35, Issue 9, 2006, Pages 523-528

  Zeng, Xuan ^a   Wu, Sha Fei ^b   Xu, Qun ^b   Xiao, Yu ^b   Liu, Tong Hua ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b NONE

Author keywords

Chromosome; Gene, myc; In situ hybridization, fluorescence; Lipoprotein lipase; Prostate neoplasms

Indexed keywords

FORMALDEHYDE; LIPOPROTEIN LIPASE; PARAFFIN;

ARTICLE; CANCER GRADING; CHINESE; CHROMOSOME 8; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; MONOSOMY; ONCOGENE C MYC; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 8; GENE DELETION; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 33750846838     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Matsuyama H, Pan Y, Oba K, et al. Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer. Clin Cancer Res, 2001, 7:3139-3143.
2. Tsuchiya N, Slezak JM, Lieber MM, et al. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer. Genes Chromosomes Cancer, 2002, 34:363-371.
3. Sato K, Qian J, Slezak JM, et al. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J Natl Cancer Inst, 1999, 91:1574-1580.
4. Miyoshi Y, Uemura H, Fujinami K, et al. Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients. Prostate, 2000, 43:225-232.
5. Gallucci M, Merola R, Farsetti A, et al. Cytogenetic profiles as additional markers pathological features in clinically localized prostate carcinoma. Cancer Lett, 2006, 237:76-82.
6. Narita S, Tsuchiya N, Wang L, et al. Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population. Int J Cancer, 2004, 112:872-876.
7. Buttya R, Sawczuk IS, Benson MC, et al. Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers. Prostate, 1987, 11:327-337.
8. Jenkins RB, Qian J, Leiber MM, et al. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res, 1997, 57:524-531.
9. Williams K, Fernandez S, Stien X, et al. Unopposed c-myc expression in benign prostatic epithelium causes a cancer phenotype. Prostate, 2005, 63:369-384.
10. Gil J, Kerai P, Lleonart M, et al. Immortalization of primary human prostate epithelial cells by c-myc. Cancer Res, 2005, 65:2179-2185.
11. Paris PL, Andaya A, Fridlyand J, et al. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet, 2004, 13:1303-1313.
12. Wang Y, Corr JG, Thaler HT, et al. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst, 1995, 87:1456-1462.
13. Bova GS, Carter BS, Bussemarkers MJ, et al. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res, 1993, 53:3869-3873.
14. Cher ML, MacGrogan D, Bookstein R, et al. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer, 1994, 11:153-162.
15. Macoska JA, Beheshti B, Rhim JS, et al. Genetic characterization of immortalized human prostate epithelial cell cultures. Evidence for structural rearrangements of chromosome 8 and i(8q) chromosome formation in primary tumor-derived cells. Cancer Genet Cytogenet, 2000, 120:50-57.